2013 American Transplant Congress
Salvage Transplantation Aligns Survival for Small and Large Hepatocellular Carcinomas in the Modern Era of Liver Surgery
INTRODUCTIONOperative management is standard treatment of hepatocellular carcinoma (HCC). In select patients, resection can offer cure or a bridge to transplantation. This study analyzed resection…2013 American Transplant Congress
Divided Daily Prednisolone Dosing Reduces Hyperglycemia after Kidney Transplantation
The pharmacokinetics of prednisolone indicate that divided twice daily (BD) dosing would produce more even drug exposure and may improve glycemia compared with daily (QD)…2013 American Transplant Congress
Surveillance for Hyperglycemia Post Kidney Transplantation: Afternoon Glucose Superior to Conventional Tests in the First 6 Weeks
Optimal screening for hyperglycemia after kidney transplantation remains uncertain. As plasma glucose peaks 7-8 hours after prednisolone administration, fasting plasma glucose (FPG) and oral glucose…2013 American Transplant Congress
Clinical Pharmacokinetics of Once-Daily Prolonged-Release Tacrolimus (Graceptor) in De Novo Kidney Transplantation
(Introduction)Graceptor (GCT) is a new formulation of tacrolimus (TRL), allows once-daily administration while showing similar efficacy and safety to the conventional Prograf (PGF), which is…2013 American Transplant Congress
Course of BK Virus Infection in Renal Transplant Recipients Treated with Cidofovir
The Methodist Hospital, Houston, TX
In renal transplantation, BK virus may contribute to graft dysfunction and graft loss. While reduction in immunosuppression is considered standard therapy for infection, data has…2013 American Transplant Congress
Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
mTOR inhibitors have the potential to reduce calcineurin inhibitor nephrotoxicity by minimizing or eliminating the need for their use. The 12 month (M) results of…2013 American Transplant Congress
Impact of mTOR and Calcineurin Inhibition on Lipid and Glucose Metabolism – 24 Month Assessment in De Novo Liver Transplant Recipients Treated with Everolimus and Tacrolimus
For the H2304 Investigators, Hamburg, Germany; Novartis Pharma AG, Basel, Switzerland
Immunosuppressants, particularly corticosteroids (CS) and calcineurin inhibitors used after liver transplantation (LTx) can adversely affect lipid metabolism. mTOR inhibition blocks insulin-stimulated lipoprotein lipase and can…2013 American Transplant Congress
There Is No Difference in Patient Survival after Liver Transplantation between Induction with Rabbit ATG and Basiliximab in Recipients with HCV, However, There Appears To Be Less Severe Fibrosis with rATG
University of Washington, Seattle
rATG has gained acceptance for induction in liver transplantation. However, due to its strength as an immunosuppressive agent, there is concern that it may be…2013 American Transplant Congress
Soluble FGL2 Mediates Acute Rejection in Renal Allograft Recipients by Inducing Tubular Epithelial Cells Apoptosis
Background: Acute rejection (AR), initiated by infiltrating alloreactive T cells, hampers renal allograft survival. Tubular epithelial cells (TECs) are primary target in AR. TECs apoptosis…2013 American Transplant Congress
Effect of Nrf2-keap1 Pathway Activation on Human Pancreatic β Cells, The
Backgrounds: Islets are known to contain low level of antioxidants which renders them vulnerable to oxidative stress. It is also known that islets are exposed…
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 178
- Next Page »